Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 72
Filter
1.
Clin Infect Dis ; 33 Suppl 2: S69-77, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11486302

ABSTRACT

By use of the National Nosocomial Infections Surveillance (NNIS) System's surgical patient surveillance component protocol, the NNIS basic risk index was examined to predict the risk of a surgical site infection (SSI). The NNIS basic SSI risk index is composed of the following criteria: American Society of Anesthesiologists score of 3, 4, or 5; wound class; and duration of surgery. The effect when a laparoscope was used was also determined. Overall, for 34 of the 44 NNIS procedure categories, SSI rates increased significantly (P< .05) with the number of risk factors present. With regard to cholecystectomy and colon surgery, the SSI rate was significantly lower when the procedure was done laparoscopically within each risk index category. With regard to appendectomy and gastric surgery, use of a laparoscope affected SSI rates only when no other risk factors were present. The NNIS basic SSI index is useful for risk adjustment for a wide variety of procedures. For 4 operations, the use of a laparoscope lowered SSI risk, requiring modification of the NNIS basic SSI risk index.


Subject(s)
Cross Infection/epidemiology , Population Surveillance , Surgical Wound Infection/epidemiology , Data Collection , Humans , Risk Factors , Time Factors , United States/epidemiology
2.
J Pediatr ; 138(5): 705-9, 2001 May.
Article in English | MEDLINE | ID: mdl-11343047

ABSTRACT

BACKGROUND: The Advisory Committee on Immunization Practices recommends routine hepatitis A vaccination of children living in communities with high rates of hepatitis A. Rates among children living in migrant farm worker families are unknown. METHODS: Participants recruited from the 1243 migrant children aged 2 to 18 years in Okeechobee County, Florida, were administered a questionnaire. A blood sample was taken for testing for antibodies to hepatitis A virus (anti-HAV), and hepatitis A vaccine was administered. RESULTS: Of 244 (20%) participating children, 125 (51%) were anti-HAV-positive. Seropositivity increased with age from 34% (2- to 5-year-olds) to 81% (>/=14-year-olds) (P <.0001). In multivariate analysis, age (odds ratio [OR] = 1.2/year; 95% CI = 1.1 to 1.3), having a Mexican-born father (OR = 12.2; 95% CI = 2.2 to 227.9), and age on moving to the United States (OR = 1.3/year; 95% CI = 1.0 to 1.6) were independently associated with anti-HAV positivity. Among US-born children aged 2 to 5 years who had never left the United States, 33% were anti-HAV-positive. CONCLUSIONS: Anti-HAV prevalence among migrant children in Okeechobee County, including the youngest US-born children, is high, indicating ongoing transmission of HAV. Children in this and other US migrant communities may benefit from hepatitis A vaccination.


Subject(s)
Emigration and Immigration , Hepatitis A/epidemiology , Adolescent , Age Factors , Child , Child, Preschool , Cross-Sectional Studies , Female , Hepatitis A/prevention & control , Hepatitis A Vaccines/therapeutic use , Humans , Logistic Models , Male , Mexico/ethnology , Multivariate Analysis , Surveys and Questionnaires , United States/epidemiology
3.
Transfusion ; 40(10): 1176-81, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11061852

ABSTRACT

BACKGROUND: As part of a nationwide program to identify persons at increased risk for HCV infection, persons who received blood from donors who later tested positive for anti-HCV are being directly notified. STUDY DESIGN AND METHODS: In December 1999, all 198 blood collection establishments (BCEs) and 5442 hospital transfusion services (TSs) in the United States were surveyed by mailed questionnaire to evaluate their progress in carrying out this notification. RESULTS: Eighty-one percent of the BCEs and 64 percent of the TSs responded. After correcting for nonresponse, an estimated 98,484 components at potential risk for transmitting HCV, according to previous testing of multiantigen-screened donors, were identified nationwide, of which 85 percent had been transfused to recipients. Lookback for these recipients was completed for 80 percent, of whom 69 percent had died. Of those living, 78 percent were successfully notified. An estimated 49.5 percent of those notified were tested; 18.9 percent of those tested were anti-HCV positive, and 32 percent of that group knew they were positive before notification. On the basis of an 85.5 percent reported completion rate for component notifications back through 1988, an estimated 1520 persons will have been newly identified as anti-HCV-positive when lookback related to multiantigen screening of donors is completed. CONCLUSION: Targeted lookback related to previous multiantigen screening of donors will identify <1 percent of the estimated 300,000 HCV-positive persons in the United States who may have acquired their infection via blood transfusion.


Subject(s)
Hepatitis C/transmission , Transfusion Reaction , DNA, Viral/genetics , Evaluation Studies as Topic , Hepatitis C/epidemiology , Humans , Nucleic Acid Amplification Techniques , Risk Factors , Surveys and Questionnaires , United States
4.
Infect Control Hosp Epidemiol ; 21(8): 510-5, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10968716

ABSTRACT

OBJECTIVE: To describe the epidemiology of nosocomial infections in combined medical-surgical (MS) intensive care units (ICUs) participating in the National Nosocomial Infection Surveillance (NNIS) System. DESIGN: Analysis of surveillance data on 498,998 patients with 1,554,070 patient-days, collected between 1992 and 1998 from 205 MS ICUs following the NNIS Intensive Care Unit protocol, representing 152 participating NNIS hospitals in the United States. RESULTS: Infections at three major sites represented 68% of all reported infections (nosocomial pneumonia, 31%; urinary tract infections (UTIs), 23%; and primary bloodstream infections (BSIs), 14%: 83% of episodes of nosocomial pneumonia were associated with mechanical ventilation, 97% of UTIs occurred in catheterized patients, and 87% of primary BSIs in patients with a central line. In patients with primary BSIs, coagulase-negative staphylococci (39%) were the most common pathogens reported; Staphylococcus aureus (12%) was as frequently reported as enterococci (11%). Coagulase-negative staphylococcal BSIs were increasingly reported over the 6 years, but no increase was seen in candidemia or enterococcal bacteremia. In patients with pneumonia, S. aureus (17%) was the most frequently reported isolate. Of reported isolates, 59% were gram-negative bacilli. In patients with UTIs, Escherichia coli (19%) was the most frequently reported isolate. Of reported isolates, 31% were fungi. In patients with surgical-site infections, Enterococcus (17%) was the single most frequently reported pathogen. Device-associated nosocomial infection rates for BSIs, pneumonia, and UTIs did not correlate with length of ICU stay, hospital bed size, number of beds in the ICU, or season. Combined MS ICUs in major teaching hospitals had higher device-associated infection rates compared to all other hospitals with combined medical-surgical units. CONCLUSIONS: Nosocomial infections in MS ICUs at the most frequent infection sites (bloodstream, urinary, and respiratory tract) almost always were associated with use of an invasive device. Device-associated infection rates were the best available comparative rates between combined MS ICUs, but the distribution of device-associated rates should be stratified by a hospital's major teaching affiliation status.


Subject(s)
Cross Infection/epidemiology , Equipment Reuse , Intensive Care Units/statistics & numerical data , Equipment and Supplies, Hospital , Health Care Surveys , Hospital Bed Capacity , Humans , Length of Stay , Prevalence , United States/epidemiology
5.
Clin Infect Dis ; 28(5): 1119-25, 1999 May.
Article in English | MEDLINE | ID: mdl-10452645

ABSTRACT

We analyzed data from a prospective observational cohort study that included 108 adult intensive care units (ICUs) in 41 United States hospitals. Use of vancomycin (defined daily doses per 1,000 patient-days), nosocomial infection rates, and proportion of all Staphylococcus aureus isolates resistant to methicillin (MRSA rate) were recorded from January 1996 through November 1997. The median rate of vancomycin use was lowest in coronary care ICUs and highest in general surgical ICUs. Prior approval before use of vancomycin was required in only 26 (24%) of the 108 ICUs. In a multivariate linear regression model, rates of MRSA, central line-associated bloodstream infection, and the type of ICU were independent predictors of vancomycin use. None of the vancomycin control practices was associated with lower rates of vancomycin use; however, it is important to recognize that this database was not designed to measure rates of inappropriate use. Vancomycin use is heavily determined by rates of endemic MRSA and central line-associated bloodstream infection. Efforts to reduce these rates through infection control activities should be included in hospitals' efforts to reduce vancomycin use.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cross Infection/drug therapy , Drug Utilization/statistics & numerical data , Intensive Care Units/statistics & numerical data , Vancomycin/therapeutic use , Adult , Cohort Studies , Cross Infection/epidemiology , Drug Costs , Drug Utilization/standards , Female , Health Services Misuse , Humans , Linear Models , Male , Methicillin Resistance , Practice Guidelines as Topic , Prospective Studies , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , United States
6.
Crit Care Med ; 27(5): 887-92, 1999 May.
Article in English | MEDLINE | ID: mdl-10362409

ABSTRACT

OBJECTIVE: To describe the epidemiology of nosocomial infections in medical intensive care units (ICUs) in the United States. DESIGN: Analysis of ICU surveillance data collected through the National Nosocomial Infections Surveillance (NNIS) System between 1992 and 1997. SETTING: Medical ICUs in the United States. PATIENTS: A total of 181,993 patients. MEASUREMENTS AND MAIN RESULTS: Nosocomial infections were analyzed by infection site and pathogen distribution. Urinary tract infections were most frequent (31%), followed by pneumonia (27%) and primary bloodstream infections (19%). Eighty-seven percent of primary bloodstream infections were associated with central lines, 86% of nosocomial pneumonia was associated with mechanical ventilation, and 95% of urinary tract infections were associated with urinary catheters. Coagulase-negative staphylococci (36%) were the most common bloodstream infection isolates, followed by enterococci (16%) and Staphylococcus aureus (13%). Twelve percent of bloodstream isolates were fungi. The most frequent isolates from pneumonia were Gram-negative aerobic organisms (64%). Pseudomonas aeruginosa (21%) was the most frequently isolated of these. S. aureus (20%) was isolated with similar frequency. Candida albicans was the most common single pathogen isolated from urine and made up just over half of the fungal isolates. Fungal urinary infections were associated with asymptomatic funguria rather than symptomatic urinary tract infections (p < .0001). Certain pathogens were associated with device use: coagulase-negative staphylococci with central lines, P. aeruginosa and Acinetobacter species with ventilators, and fungal infections with urinary catheters. Patient nosocomial infection rates for the major sites correlated strongly with device use. Device exposure was controlled for by calculating device-associated infection rates for bloodstream infections, pneumonia, and urinary tract infections by dividing the number of device-associated infections by the number of days of device use. There was no association between these device-associated infection rates and number of hospital beds, number of ICU beds, or length of stay. There is a considerable variation within the distribution of each of these infection rates. CONCLUSIONS: The distribution of sites of infection in medical ICUs differed from that previously reported in NNIS ICU surveillance studies, largely as a result of anticipated low rates of surgical site infections. Primary bloodstream infections, pneumonia, and urinary tract infections associated with invasive devices made up the great majority of nosocomial infections. Coagulase-negative staphylococci were more frequently associated with primary bloodstream infections than reported from NNIS ICUs of all types in the 1980s, and enterococci were a more frequent isolate from bloodstream infections than S. aureus. Fungal urinary tract infections, often asymptomatic and associated with catheter use, were considerably more frequent than previously reported. Invasive device-associated infections were associated with specific pathogens. Although device-associated site-specific infection rates are currently our most useful rates for performing comparisons between ICUs, the considerable variation in these rates between ICUs indicates the need for further risk adjustment.


Subject(s)
Cross Infection/epidemiology , Intensive Care Units/statistics & numerical data , Adult , Catheterization, Central Venous/adverse effects , Cross Infection/etiology , Cross Infection/microbiology , Equipment and Supplies/adverse effects , Humans , Infection Control , Length of Stay/statistics & numerical data , Pneumonia/epidemiology , Pneumonia/etiology , Pneumonia/microbiology , Population Surveillance , Respiration, Artificial/adverse effects , Risk Factors , United States/epidemiology , Urinary Catheterization/adverse effects , Urinary Tract Infections/epidemiology , Urinary Tract Infections/etiology , Urinary Tract Infections/microbiology
7.
Pediatrics ; 103(4): e39, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10103331

ABSTRACT

OBJECTIVES: To describe the epidemiology of nosocomial infections in pediatric intensive care units (ICUs) in the United States. BACKGROUND: Patient and ICU characteristics in pediatric ICUs suggest the pattern of nosocomial infections experienced may differ from that seen in adult ICUs. METHODS: Data were collected between January 1992 and December 1997 from 61 pediatric ICUs in the United States using the standard surveillance protocols and nosocomial infection site definitions of the National Nosocomial Infections Surveillance System's ICU surveillance component. RESULTS: Data on 110 709 patients with 6290 nosocomial infections were analyzed. Primary bloodstream infections (28%), pneumonia (21%), and urinary tract infections (15%) were most frequent and were almost always associated with use of an invasive device. Primary bloodstream infections and surgical site infections were reported more frequently in infants aged 2 months or less as compared with older children. Urinary tract infections were reported more frequently in children >5 years old compared with younger children. Coagulase-negative staphylococci (38%) were the most common bloodstream isolates, and aerobic Gram-negative bacilli were reported in 25% of primary bloodstream infections. Pseudomonas aeruginosa (22%) was the most common species reported from pneumonia and Escherichia coli (19%), from urinary tract infections. Enterobacter spp. were isolated with increasing frequency from pneumonia and were the most common Gram-negative isolates from bloodstream infections. Device-associated infection rates for bloodstream infections, pneumonia, and urinary tract infections did not correlate with length of stay, the number of hospital beds, or season. CONCLUSIONS: In pediatric ICUs, bloodstream infections were the most common nosocomial infection. The distribution of infection sites and pathogens differed with age and from that reported from adult ICUs. Device-associated infection rates were the best rates currently available for comparisons between units, because they were not associated with length of stay, the number of beds in the hospital, or season.


Subject(s)
Cross Infection/epidemiology , Intensive Care Units, Pediatric/statistics & numerical data , Pneumonia/epidemiology , Sepsis/epidemiology , Urinary Tract Infections/epidemiology , Adolescent , Age Factors , Catheterization/adverse effects , Chi-Square Distribution , Child , Child, Preschool , Cross Infection/microbiology , Cross Infection/virology , Female , Humans , Infant , Infant, Newborn , Linear Models , Male , Pneumonia/microbiology , Pneumonia/virology , Respiration, Artificial/adverse effects , Risk Factors , Sepsis/microbiology , Sepsis/virology , Staphylococcal Infections/epidemiology , Surgical Wound Infection/epidemiology , Surgical Wound Infection/microbiology , United States/epidemiology , Urinary Tract Infections/microbiology , Urinary Tract Infections/virology
8.
Am J Cardiol ; 82(6): 789-93, 1998 Sep 15.
Article in English | MEDLINE | ID: mdl-9761092

ABSTRACT

To describe the epidemiology of nosocomial infections in Coronary Care Units (CCUs) in the United States, we analyzed data collected between 1992 and 1997 using the standard protocols of the National Nosocomial Infections Surveillance (NNIS) Intensive Care Unit (ICU) surveillance component. Data on 227,451 patients with 6,698 nosocomial infections were analyzed. Urinary tract infections (35%), pneumonia (24%), and primary bloodstream infections (17%) were almost always associated with use of an invasive device (93% with a urinary catheter, 82% with a ventilator, 82% with a central line, respectively). The distribution of pathogens differed from that reported from other types of ICUs. Staphylococcus aureus (21%) was the most common species reported from pneumonia and Escherichia coli (27%) from urine. Only 10% of reported urine isolates were Candida albicans. S. aureus (24%) was the more common bloodstream isolate than enterococci (10%). The mean overall patient infection rate was 2.7 infections per 100 patients. Device-associated infection rates for bloodstream infections, pneumonia, and urinary tract infections did not correlate with length of stay, number of hospital beds, number of CCU beds, or the hospital teaching affiliation, and were the best rates for comparisons between units. Use of invasive devices was lower than in other types of ICUs. Overall patient infection rates were lower than in other types of ICUs, which is largely explained by lower rates of invasive device usage.


Subject(s)
Coronary Care Units , Cross Infection/epidemiology , Adult , Bacteria/isolation & purification , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Coronary Care Units/statistics & numerical data , Cross Infection/microbiology , Equipment Contamination , Fungi/isolation & purification , Humans , Incidence , Length of Stay , Mycoses/epidemiology , Mycoses/microbiology , Retrospective Studies , United States/epidemiology
9.
Infect Control Hosp Epidemiol ; 19(5): 308-16, 1998 May.
Article in English | MEDLINE | ID: mdl-9613690

ABSTRACT

OBJECTIVE: To assess the accuracy of nosocomial infections data reported on patients in the intensive-care unit by nine hospitals participating in the National Nosocomial Infections Surveillance (NNIS) System. DESIGN: A pilot study was done in two phases to review the charts of selected intensive-care-unit patients who had nosocomial infections reported to the NNIS System. The charts of selected high- and low-risk patients in the same cohort who had no infections reported to the NNIS System also were included. In phase I, trained data collectors reviewed a sample of charts for nosocomial infections. Retrospectively detected infections that matched with previously reported infections were deemed to be true infections. In phase II, two Centers for Disease Control and Prevention (CDC) epidemiologists reexamined a sample of charts for which a discrepancy existed. Each sampled infection either was confirmed or disallowed by the epidemiologists. Confirmed infections also were deemed to be true infections. True infections from both phases were used to estimate the accuracy of reported NNIS data by calculating the predictive value positive, sensitivity, and specificity at each major infection site and the "other sites." RESULTS: The data collectors examined a total of 1,136 patients' charts in phase I. Among these charts were 611 infections that the study hospitals had reported to the CDC. The data collectors retrospectively matched 474 (78%) of the prospectively identified infections, but also detected 790 infections that were not reported prospectively. Phase II focused on the discrepant infections: the 137 infections that were identified prospectively and reported but not detected retrospectively, and the 790 infections that were detected retrospectively but not reported previously. The CDC epidemiologists examined a sample of 113 of the discrepant reported infections and 369 of the discrepant detected infections, and estimated that 37% of all discrepant reported infections and 43% of all discrepant detected infections were true infections. The predictive value positive for reported bloodstream infections, pneumonia, surgical-site infection, urinary tract infection, and other sites was 87%, 89%, 72%, 92%, and 80%, respectively; the sensitivity was 85%, 68%, 67%, 59%, and 30%, respectively; and the specificity was 98.3%, 97.8%, 97.7%, 98.7%, and 98.6%, respectively. CONCLUSIONS: When the NNIS hospitals in the study reported a nosocomial infection, the infection most likely was a true infection, and they infrequently reported conditions that were not infections. The hospitals also identified and reported most of the nosocomial infections that occurred in the patients they monitored, but accuracy varied by infection site. Primary bloodstream infection was the most accurately identified and reported site. Measures that will be taken to improve the quality of the infection data reported to the NNIS System include reviewing the criteria for definitions of infections and other data fields, enhancing communication between the CDC and NNIS hospitals, and improving the training of surveillance personnel in NNIS hospitals.


Subject(s)
Cross Infection/epidemiology , Disease Notification/standards , Intensive Care Units/statistics & numerical data , Population Surveillance , Data Collection , Humans , Pilot Projects , United States
10.
Infect Control Hosp Epidemiol ; 19(4): 260-1, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9605275

ABSTRACT

Among surgical intensive-care units (ICUs), we assessed differences in risk-adjusted nosocomial infection rates between cardiothoracic (CT) and general surgery ICUs, using National Nosocomial Infection Surveillance data from 1987 to 1995. Device-associated rates and average length of stay were significantly lower in CT ICUs. Comparisons of risk-adjusted nosocomial infection rates among CT ICUs should be made separately from rates from general surgery ICUs.


Subject(s)
Cross Infection/epidemiology , Intensive Care Units/statistics & numerical data , Surgical Procedures, Operative/classification , Humans , Intensive Care Units/classification , Length of Stay , Risk Factors , Statistics, Nonparametric , Thoracic Surgery/statistics & numerical data , United States/epidemiology
11.
N Engl J Med ; 337(21): 1485-90, 1997 Nov 20.
Article in English | MEDLINE | ID: mdl-9366579

ABSTRACT

BACKGROUND: The average risk of human immunodeficiency virus (HIV) infection after percutaneous exposure to HIV-infected blood is 0.3 percent, but the factors that influence this risk are not well understood. METHODS: We conducted a case-control study of health care workers with occupational, percutaneous exposure to HIV-infected blood. The case patients were those who became seropositive after exposure to HIV, as reported by national surveillance systems in France, Italy, the United Kingdom, and the United States. The controls were health care workers in a prospective surveillance project who were exposed to HIV but did not seroconvert. RESULTS: Logistic-regression analysis based on 33 case patients and 665 controls showed that significant risk factors for seroconversion were deep injury (odds ratio= 15; 95 percent confidence interval, 6.0 to 41), injury with a device that was visibly contaminated with the source patient's blood (odds ratio= 6.2; 95 percent confidence interval, 2.2 to 21), a procedure involving a needle placed in the source patient's artery or vein (odds ratio=4.3; 95 percent confidence interval, 1.7 to 12), and exposure to a source patient who died of the acquired immunodeficiency syndrome within two months afterward (odds ratio=5.6; 95 percent confidence interval, 2.0 to 16). The case patients were significantly less likely than the controls to have taken zidovudine after the exposure (odds ratio=0.19; 95 percent confidence interval, 0.06 to 0.52). CONCLUSIONS: The risk of HIV infection after percutaneous exposure increases with a larger volume of blood and, probably, a higher titer of HIV in the source patient's blood. Postexposure prophylaxis with zidovudine appears to be protective.


Subject(s)
Blood-Borne Pathogens , HIV Infections/transmission , HIV Seropositivity/epidemiology , Health Personnel , Infectious Disease Transmission, Patient-to-Professional , Occupational Diseases/epidemiology , Analysis of Variance , Anti-HIV Agents/therapeutic use , Case-Control Studies , Female , HIV Infections/prevention & control , Humans , Logistic Models , Male , Needlestick Injuries/complications , Occupational Diseases/prevention & control , Population Surveillance , Risk Factors , Wounds, Stab/complications , Zidovudine/therapeutic use
12.
Infect Control Hosp Epidemiol ; 18(7): 492-8, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9247832

ABSTRACT

BACKGROUND: In addition to single-hospital outbreaks, interhospital transmission of extended-spectrum beta-lactam-resistant (ESBLR) Klebsiella pneumoniae has been suspected in some reports. However, these studies lacked sufficient epidemiological information to confirm such an occurrence. METHODS: We reviewed the surveillance data reported to the National Nosocomial Infections Surveillance (NNIS) System during 1986 to 1993 for K pneumoniae isolates and their susceptibility to either ceftazidime, cefotaxime, ceftriaxone, or aztreonam. Pulsed-field gel electrophoresis (PFGE) was used to study available ESBLR K pneumoniae isolates. RESULTS: Among 8,319 K pneumoniae isolates associated with nosocomial infections, 727 (8.7%) were resistant or had intermediate-level resistance to at least one of these antibiotics. One hospital (hospital A) accounted for 321 isolates (44.2%) of ESBLR K pneumoniae. During 1986 to 1993, the percentage of K pneumoniae isolates that were ESBLR increased from 0 to 57.7% in hospital A, from 0 to 35.6% in NNIS hospitals 0 to 20 miles from hospital A (area B), and from 1.6 to 7.3% in NNIS hospitals more than 20 miles from hospital A, including hospitals located throughout the United States. Analysis of PFGE restriction profiles showed a genetic relationship between a cluster of isolates from hospital A and some isolates from one hospital in area B, and consecutive admission in these two hospitals was confirmed for two patients from whom isolates were available. CONCLUSIONS: These data provide evidence of interhospital transmission of ESBLR K pneumoniae in one region of the United States and stress the interrelationship between hospitals when trying to control antimicrobial resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cross Infection/epidemiology , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/drug effects , Population Surveillance , Cross Infection/drug therapy , Cross Infection/transmission , DNA, Bacterial/analysis , Humans , Klebsiella Infections/drug therapy , Klebsiella Infections/transmission , Klebsiella pneumoniae/genetics , Molecular Epidemiology , Regression Analysis , United States/epidemiology , beta-Lactams
13.
Pediatrics ; 98(3 Pt 1): 357-61, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8784356

ABSTRACT

BACKGROUND: Nosocomial infections result in considerable morbidity and mortality among neonates in high-risk nurseries (HRNs). PURPOSE: To examine the epidemiology of nosocomial infections among neonates in level III HRNs. METHODS: Data were collected from 99 hospitals with HRNs participating in the National Nosocomial Infections Surveillance system, which uses standard surveillance protocols and nosocomial infection site definitions. The data included information on maternal acquisition of and risk factors for infection, such as device exposure, birth weight category (< or = 1000, 1001 through 1500, 1501 through 2500, and > 2500 g), mortality, and the relationship of the nosocomial infection to death. RESULTS: From October 1986 through September 1994, these hospitals submitted data on 13 179 nosocomial infections. The bloodstream was the most frequent site of nosocomial infection in all birth weight groups. Nosocomial pneumonia was the second most common infection site, followed by the gastrointestinal and eye, ear, nose, and throat sites. The most common nosocomial pathogens among all neonates were coagulase-negative staphylococci, Staphylococcus aureus, enterococci, Enterobacter sp, and Escherichia coli. Group B streptococci were associated with 46% of bloodstream infections that were maternally acquired; coagulase-negative staphylococci were associated with 58% of bloodstream infections that were not maternally acquired, most of which (88%) were associated with umbilical or central intravenous catheters. CONCLUSIONS: Bloodstream infections, the most frequent nosocomial infections in all birth weight groups, should be a major focus of surveillance and prevention efforts in HRNs. For bloodstream infections, stratification of surveillance data by maternal acquisition will help focus prevention efforts for group B streptococci outside the HRN. Within the nursery, bloodstream infection surveillance should focus on umbilical or central intravenous catheter use, a major risk factor for infection.


Subject(s)
Bacterial Infections/epidemiology , Cross Infection/epidemiology , Nurseries, Hospital , Bacterial Infections/transmission , Birth Weight , Cross Infection/transmission , Hospital Mortality , Humans , Incidence , Infant, Newborn , Infectious Disease Transmission, Vertical/statistics & numerical data , Morbidity , Population Surveillance , Risk Factors , United States/epidemiology
14.
Infect Control Hosp Epidemiol ; 16(12): 703-11, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8683088

ABSTRACT

OBJECTIVE: To study the epidemiology and preventability of blood contact with skin and mucous membranes during surgical procedures. DESIGN: Observers present at 1,382 surgical procedures recorded information about the procedure, the personnel present, and the contacts that occurred. SETTING: Four US teaching hospitals during 1990. PARTICIPANTS: Operating room personnel in five surgical specialties. MAIN OUTCOME MEASURES: Numbers and circumstances of contact between the patient's blood (or other infective fluids) and surgical personnel's mucous membranes (mucous membrane contacts) or skin (skin contacts, excluding percutaneous injuries). RESULTS: A total of 1,069 skin (including 620 hand, 258 body, and 172 face) and 32 mucous membrane (all affecting eyes) contacts were observed. Surgeons sustained most contacts (19% had > or = 1 skin contact and 0.5% had > or = 1 mucous membrane-eye contact). Hand contacts were 72% lower among surgeons who double gloved, and face contacts were prevented reliably by face shields. Mucous membrane-eye contacts were significantly less frequent in surgeons wearing eyeglasses and were absent in surgeons wearing goggles or face shields. Among surgeons, risk factors for skin contact depended on the area of contact: hand contacts were associated most closely with procedure duration (adjusted odds ratio [OR], 9.4; > or = 4 versus < 1 hour); body contacts (arms, legs, and torso) with estimated blood losses (adjusted OR, 8.4; > or = 1,000 versus < 100 mL); and face contacts, with orthopedic service (adjusted OR, 7.5 compared with general surgery). CONCLUSION: Skin and mucous membrane contacts are preventable by appropriate barrier precautions, yet occur commonly during surgery. Surgeons who perform procedures similar to those included in this study should strongly consider double gloving, changing gloves routinely during surgery, or both.


Subject(s)
Blood-Borne Pathogens , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Surgical Procedures, Operative , Adult , Chicago , Conjunctiva , Face , Gloves, Surgical , Hand , Humans , Logistic Models , Mucous Membrane , New York City , Protective Clothing/statistics & numerical data , Skin
15.
Am J Infect Control ; 23(6): 364-8, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8821112

ABSTRACT

OBJECTIVE: To study changes in the use of National Nosocomial Infections Surveillance System (NNIS) surveillance components since 1986 that could reflect an evolution in the way in which NNIS hospitals conduct surveillance of nosocomial infections. METHOD: We analyzed NNIS data from 1986 to 1993 collected at the 199 US hospitals that participated in the NNIS system during this period. RESULTS: The number of hospitals participating in the NNIS system increased threefold between 1986 and 1993. A parallel increase was noticed in the amount of surveillance data for all NNIS components except for the hospital-wide component. The percentage of all hospitals reporting at least 1 calendar month per year of data from the hospital-wide component decreased from 95% in 1986 to 37% in 1993. During this period, use of the hospital-wide component was greater among the hospitals whose first participation in the NNIS system occurred before 1987. CONCLUSION: Interest by NNIS hospitals in the hospital-wide component apparently decreased between 1987 and 1993. In contrast, the interest in NNIS components that allow calculation of risk-adjusted nosocomial infection rates (intensive care unit, high-risk nursery, and surgical patient components) increased dramatically after 1986. This increased interest in surveillance with NNIS components that allow risk adjustment and interhospital comparison of infection rates suggests that the feasibility of collection of and interest in such data are high.


Subject(s)
Cross Infection/epidemiology , Hospitals , Population Surveillance/methods , Epidemiologic Methods , Female , Hospital Bed Capacity/statistics & numerical data , Hospitals/statistics & numerical data , Humans , Male , Risk Factors , Surveys and Questionnaires , Time Factors , United States/epidemiology
17.
J Clin Microbiol ; 33(11): 3008-18, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8576363

ABSTRACT

Since the early 1970s, the synergistic activity of an aminoglycoside with a cell wall-active agent has been predicted by determining the ability of an enterococcus to grow in the presence of high levels of the aminoglycoside (usually > or = 2,000 micrograms/ml). However, a variety of media and concentrations of aminoglycosides has been used for this screening procedure. In the present study, we sought to optimize the agar dilution, broth microdilution, and disk diffusion tests used to detect high-level gentamicin and streptomycin resistance in enterococci. For dilution tests, brain heart infusion agar or broth gave the best growth and performance. For agar dilution, 500 micrograms of gentamicin per ml, 2,000 micrograms of streptomycin per ml, and an inoculum of 1 x 10(6) CFU/ml were optimal, while for broth microdilution, 500 micrograms of gentamicin per ml, 1,000 micrograms of streptomycin per ml, and an inoculum of 5 x 10(5) CFU/ml were best. Growth of more than one colony in the agar dilution test was determined to be the best indicator of high-level resistance. For disk diffusion, Mueller-Hinton agar, 120-micrograms gentamicin disks, and 300-micrograms streptomycin disks with breakpoints of no zone for resistance and > or = 10 mm for susceptibility gave the best sensitivity and specificity if results for strains with zones of 7 to 9 mm are considered inconclusive, indicating that a broth or agar test should be performed to determine susceptibility or resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Enterococcus/drug effects , Microbial Sensitivity Tests/methods , Base Sequence , Biological Specimen Banks , Culture Media , Dose-Response Relationship, Drug , Drug Resistance, Microbial , Enterococcus/genetics , Evaluation Studies as Topic , Genes, Bacterial , Gentamicins/pharmacology , Microbial Sensitivity Tests/standards , Molecular Sequence Data , Species Specificity , Streptomycin/pharmacology
18.
J Am Dent Assoc ; 126(9): 1237-42, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7560583

ABSTRACT

The authors found that 19 percutaneous exposures among dental workers occurred both during and after use of instruments such as syringe needles and scalers. Specific information about the device and action associated with an exposure is important for prevention efforts, including safer instruments and work practices. Most of these exposures probably involved smaller, rather than larger, amounts of blood infected with the human immunodeficiency virus. To our knowledge, none of the exposures resulted in HIV transmission to an enrolled dental worker.


Subject(s)
Dental Instruments/adverse effects , Dentistry , HIV Infections/transmission , Occupational Exposure , Wounds, Penetrating/etiology , Accidents, Occupational , Dental Assistants , Dental Hygienists , Dentists , Humans , Needlestick Injuries/etiology , Risk Factors
19.
Ann Emerg Med ; 25(6): 776-9, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7755199

ABSTRACT

STUDY OBJECTIVE: To assess the nature and frequency of blood contact (BC) among emergency medical service (EMS) workers. DESIGN: During an 8-month period, we interviewed EMS workers returning from emergency transport calls on a sample of shifts. We simultaneously conducted an HIV seroprevalence survey among EMS-transported patients at receiving hospitals served by these workers. SETTING: Three US cities with high AIDS incidence. PARTICIPANTS: EMS workers. RESULTS: During 165 shifts, 2,472 patients were attended. Sixty-two BCs (1 needlestick and 61 skin contacts) were reported. Individual EMS workers had a mean of 1.25 BCs, including .02 percutaneous exposures, per 100 patients attended. The estimated annual frequency of BC for an EMS worker at the study sites was 12.3, including .2 percutaneous exposures. For 93.5% of the BCs, the HIV serostatus of the source patients was unknown to the EMS worker. HIV seroprevalences among EMS-transported patients at the three receiving hospital emergency departments were 8.3, 7.7, and 4.1 per 100 patients; the highest rates were among male patients 15 to 44 years old who presented with pneumonia. CONCLUSION: EMS personnel regularly experience BCs, most of which are skin contacts. Because the HIV serostatus of the patient is usually unknown, EMS workers should practice universal precautions. Postexposure management should include a mechanism for voluntary HIV counseling and testing of the patient after transport and transmittal of the results to the EMS.


Subject(s)
Blood , Emergency Medical Technicians , Occupational Exposure , Adolescent , Adult , Child , Child, Preschool , Cross Infection/prevention & control , Female , HIV Seropositivity , Humans , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Male , Middle Aged , Needlestick Injuries , Transportation of Patients
20.
Ann Intern Med ; 122(9): 653-7, 1995 May 01.
Article in English | MEDLINE | ID: mdl-7702226

ABSTRACT

OBJECTIVE: To assess the risk for transmission of the human immunodeficiency virus (HIV) from an infected health care worker to patients. DESIGN: Survey of investigators from health departments, hospitals, and other agencies who had elected to notify patients who had received care from health care workers infected with HIV. MEASUREMENTS: Information was collected about infected health care workers, their work practices, their patients' HIV test results, procedures that they did on those of their patients who were tested for HIV, and patient notification procedures. RESULTS: As of 1 January 1995, information about investigations of 64 health care workers infected with HIV was reported to the Centers for Disease Control and Prevention; HIV test results were available for approximately 22,171 patients of 51 of the 64 health care workers. For 37 of the 51 workers, no seropositive patients were reported among 13,063 patients tested for HIV. For the remaining 14 health care workers, 113 seropositive patients were reported among 9108 patients. Epidemiologic and laboratory follow-up did not show any health care worker to have been a source of HIV for any of the patients tested. CONCLUSION: Despite limitations, these data are consistent with previous assessments that state that the risk for transmission of HIV from a health care worker to a patient is very small. These data also support current recommendations that state that retrospective patient notification need not be done routinely.


Subject(s)
HIV Infections/transmission , Health Personnel , Infectious Disease Transmission, Professional-to-Patient , Centers for Disease Control and Prevention, U.S. , Databases, Factual , Disclosure , Follow-Up Studies , Humans , Retrospective Studies , Risk Factors , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...